129257 - PPIs in GORD: a stepped approach - Clinical Audit
- : Online
This Clinical e-Audit aims to optimise the prescribing of proton pump inhibitors (PPIs) for patients with GORD in line with best practice guidelines and Quality Use of Medicines (QUM) principles. This includes guidance on initiating PPIs and developing a patient action plan, implementing strategies to step-down PPI treatment and manage potential rebound acid hypersecretion. This Audit enables you to reflect on the whole journey of PPI prescribing for your patients with GORD, from start to stop, and how to effectively step down.Relevance to General Practice
Current guidelines for the management of GORD recommend starting treatment on a standard-dose PPI for 4-8 weeks, followed by regular reviews, with the aim of stepping down the dose or stopping the medicine completely. However many patients using PPIs long term, with overuse occurring often without an appropriate indication. While PPIs are generally safe, there is some emerging evidence of rare but serious adverse effects that need to be considered.
There is a need to revisit PPI medicines to ensure that QUM principles are applied when prescribing PPIs in GORD. This Clinical e-Audit is designed to equip GPs with the confidence to optimise PPI prescribing in line with guideline recommendations by reviewing current practice the management of GORD. This quality improvement activity provides evidence-based guidance on starting, stepping down and stopping PPIs, as well as long-term risks.